LMAT - CIK 0001158895
The table below shows LEMAITRE VASCULAR INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $15.09M | $9.04M | $5.07M | $2.28M | $4.71M | $6.07M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$13.12M | -$4.32M | -$2.36M | -$2.96M | -$536.00K | -$1.06M |
| Dividends paid | $5.71M | $4.52M | $3.59M | $3.10M | $2.74M |
LEMAITRE VASCULAR INC reported operating cash flow of $81.25M for fiscal year 2025. That is up 84.1% from $44.12M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $16.90M (FY 2016) to $81.25M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.26M |
| Stock buybacks | $460.00K | $601.00K | $358.00K | $172.00K | $145.00K | $88.00K |
| Financing cash flow | -$3.22M | -$5.24M | $39.00K | -$1.82M | -$2.38M | -$7.96M |